Come up with a name for your new list and we'll add to it:
MenoGeniX raised a round of funding on May 03, 2018. Investors include
National Institute on Aging.
MenoGeniX is a clinical stage biotechnology company focused on the development of an approved drug, in a new indication, menopause, and the menopause-like symptoms that occur in certain breast and pro…